Target intelligence / Profile preview

Outer membrane protein P2 of nontypeable Haemophilus influenzae (OMP P2)

Target
OMP P2
Molecular classification
Porin, Outer membrane protein, Bacterial surface antigen
01

Overview

Outer membrane protein P2 (OMP P2) is the most abundant surface protein and the primary porin of nontypeable Haemophilus influenzae (NTHi), a major human respiratory pathogen (UniProt: P06120). It functions as a non-specific channel for the diffusion of small solutes across the bacterial outer membrane and plays a critical role in bacterial fitness and host cell adhesion (PubMed: 15210883). Because NTHi lacks a polysaccharide capsule, OMP P2 and other surface antigens are the primary targets for the host immune response and are central to vaccine development efforts (PubMed: 11514317). OMP P2 is highly immunogenic, but its external loops exhibit significant sequence variability among strains, allowing the bacteria to undergo antigenic variation and evade host immunity (PubMed: 25605281). This variability presents a significant challenge for the development of a universal vaccine, as antibodies generated against one strain may not protect against others. Current therapeutic strategies focus on identifying conserved regions within OMP P2 and other surface antigens to induce broadly protective bactericidal antibodies. These antigens are particularly relevant in the context of preventing otitis media in children and exacerbations of chronic obstructive pulmonary disease in adults.

Other names
Porin P2Major outer membrane protein P2OmpP2Nontypeable Haemophilus influenzae surface antigens
02

Mechanism of action

Induction of bactericidal and opsonizing antibodies through active immunization to prevent bacterial colonization and infection.

03

Biological functions

Nutrient transportBacterial adhesionImmune evasionMembrane permeability
04

Disease associations

Otitis mediaChronic obstructive pulmonary disease (COPD) exacerbationSinusitisPneumoniaInfection
05

Safety considerations

Antigenic variation leading to strain-specific immunityPotential for limited cross-protectionRisk of immune escape
06

Interacting drugs

Investigational NTHi vaccines

1 more in the full profile.

07

Biomarkers

Anti-OMP P2 antibody titersSerum bactericidal activity (SBA)

Beyond the preview

Go deeper on Outer membrane protein P2 of nontypeable Haemophilus influenzae (OMP P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Outer membrane protein P2 of nontypeable Haemophilus influenzae (OMP P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call